Timothy Geary obtained his PhD in 1980 from the University of Michigan (Pharmacology). From 1980-1985, he was an NIH Postdoctoral Fellow and Research Assistant Professor in malaria research at Michigan State University. From 1985 to 2005, he was a research scientist in the veterinary parasitology group at the Upjohn Company (Pharmacia, then Pfizer) in Kalamazoo, Michigan. In 2005, Tim joined McGill University as a Tier I Canada Research Chair and Professor in the Institute of Parasitology, and became its Director in 2007. He has received many awards from parasitology societies, is on the editorial boards of 7 scientific journals and has published some 225 articles and book chapters. He consults for many pharmaceutical and biotechnology companies on antiparasitic drug discovery and development and for non-profit organizations, including the Bill and Melinda Gate Foundation. His current research interests lie in the analysis of mechanisms of drug action and resistance and on the identification of miRNAs, metabolites and proteins used by nematode parasites to influence host immune response.